Research - Madison, Wisconsin, United States
PeptiMed is a Wisconsin-based, seed-stage biopharmaceutical company that is developing a potent siRNA molecule to down-regulate an oncogene target to treat cancer, as well as a novel nanoparticle delivery system to enable its use in animals and humans. PeptiMed was founded by repeat biotech entrepreneurs with combined 100 years of academic and corporate experience in cancer R&D.
Nginx
New Relic
Google Tag Manager
Amazon AWS
Bootstrap Framework
Mobile Friendly